Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Editorial · Feb 2021Exact title match Editorial · 31 Jul 2020Exact title match Ovarian Cancer
Conference abstract · 19 May 2016 Mesothelin Expression in Ovarian Cancer and its potential as Targeted Ovarian cancer Immunotherapy
Ovarian cancer is the fourth most common cause of cancer death in women. Most patients are diagnosed at stage III and IV, with resultant low relative-survival rates. The current ... recognize and eliminate microscopic…
Case report · 2 Mar 2023 Ovarian Cancer Epigenetic Modifications Epithelial Ovarian Cancer Metastases (EOC)
EOC is typically caused by direct cell slipping from the primary excrescence
Conference abstract · 23 Jul 2018 Ovarian cancer: Single institutional based data
Background: Ovarian cancer often has no symptoms at the early stages, so the disease is generally advanced when it is diagnosed. Ovarian cancer is the seventh most common cancer ... women worldwide and 18 most common…
Conference abstract · 17 Jul 2017 ITM2A, a frequently down-regulation in epithelial ovarian cancer, enhance anti-tumor effects and chemosensitivity of ovarian cancer
transmembrane protein of unknown biological mechanism. The ITM2A protein expression was down-regulated in ovarian cancer tissue samples and cancer cells as compared to normal cells (p<0.0001) using immunohistochemistry…
Conference abstract Ovarian cancer stem cells serve as a new prophylactic vaccine for ovarian cancer
offer a number of advantages for cancer treatment. In the study, the vaccination of cancer stem cells (CSCs) with high expression of the type I receptor tyrosine kinase-like orphan ... murine model for the vaccine’s…
Short communication · 2021 ROS and miRNA signaling in ovarian cancer angiogenesis, tumor growth and treatment resistance
Ovarian cancer represents the fifth leading cause of cancer-related death among women. However, the mechanisms of ovarian cancer development and the treatment resistance remain to be elucidated. We found ... that…
Research article · 2015 Awareness of Signs and Symptoms of Ovarian Cancer among Gynecology Nurses in a Large Teaching Hospital in the UK (Awareness of Ovarian Cancer among Gynecology Nurses)
Background: The overall mortality of ovarian cancer is high because of its late presentation, with over 80% of patients presenting with advanced disease largely due to the vague symptoms ... early stages. Ninety percent…
Conference abstract · 20 Jul 2017 Vacuolar ATPase 'a2' subunit is a tumor associated antigen candidate for diagnosis and treatment of ovarian cancer
early diagnosis and development of alternate therapies is vital to patient outcome in ovarian cancer (OVCA). Tumor associated vacuolar-H+-ATPases (V-ATPases) are multi-subunit proton-pumps that acidify ... potential…
Conference abstract · 23 Jul 2018 Nano particle formulation Paclitaxel (Nanoxel) - Alternative to conventional Paclitaxel in the treatment of advanced epithelial ovarian cancer as neo adjuvant chemotherapy
Background: Epithelial ovarian cancer (EOC) is the leading cause of death in women with gynecological malignancy. Approximately 70% of women with EOC are diagnosed with advanced stage of disease, which ... evaluate the…
Conference abstract · 13 Sep 2017 Role of gynae oncology specialist nurses in improving quality of life assessment in ovarian cancer: Experience from a tertiary referral center in Eastern India
Tata Medical Canter, dedicated clinical nurse specialists are involved in a QOL study in ovarian cancer (SOCQER-IND). Objectives: To assess whether pre and post-operative counselling and follow
Conference abstract · 1 May 2020 Gynecologic Cancer 2017: Ovarian cancer screening and the clinical surveillance of ovarian abnormalities- Edward J Pavlik- The University of Kentucky, USA
normal sources are tumors inside the endometrium, bosom, colon, stomach, and cervix. The earlier ovarian cancer is diagnosed and treated, the higher the prospect of a cure. But often ... cancer in check for several…
Conference abstract · 30 Mar 2018 Expression of novel cancer biomarkers in ovarian cancer tissues and cells
MAPs are involved in the continuous assembly and disassembly of tubulin into
Review article · 2013 Updates on Anti-Cancer Therapy in Ovarian Cancer
Drug discovery in the ovarian cancer arena continues to launch important new clinical trials. Many biologic agents are being studied in phase II and phase III clinical trials for recurrent ... continue to demonstrate…
Conference abstract · 7 Mar 2019 Pseudorelapse and cancer stem cells in ovarian cancer
late image effects after antigen-specific multi-peptide immunotherapy and immunomodulation in epithelial ovarian cancer. Most of the potential effects in pseudorelapse are mainly unknown for the oncologists and…
Conference abstract · 2018 Clinical Oncology 2018: Pseudo-relapse and cancer stem cells in ovarian cancer - Martin Orlando Rosas Delgado - Sonora Cancer Research Center (CICS Sonora), Mexico
late image effects after antigen-specific multi-peptide immunotherapy and immunomodulation in epithelial ovarian cancer. Most of the potential effects in pseudo-progression and pseudo-relapse are mainly unknown…
Conference abstract · 2018 Pseudo-relapse and cancer stem cells in ovarian cancer
late image effects after antigen-specific multi-peptide immunotherapy and immunomodulation in epithelial ovarian cancer. Most of the potential effects in pseudo-progression and pseudo-relapse are mainly unknown…
Review article · 2014 Ovarian Cancer Recurrence: Role of Ovarian Stem Cells and Epithelial-to-Mesenchymal Transition
Despite the remarkable progress made in delineating the pathogenesis of ovarian tumor during the last two decades, the 5 years survival of these patients is very low, with ... cancer stem cells and epithelial to…
Article · 24 Apr 2024 Differentiation between Tuberculosis Peritonitis and Cancerous Peritonitis Caused by Advanced Ovarian Cancer: A Short Communication
Laparoscopy for intra-abdominal? Exploration and tissue? Sampling is useful in advanced ovarian cancers, in which it is presumed to be difficult to achieve complete? Tumour reduction in the initial ... surgery. We…
Case report · 2 Jan 2023 Reproductive Cancer and the Risk of Ovarian Cancer, Hormonal Imbalances in Female
stromal cells. When these cells become abnormal, they can divide and form tumors. Ovarian cancer is a cancerous tumor of an ovary. It may originate from the ovary itself ... those who reach menopause at an older age are…
Conference abstract · 20 Jul 2015 IGF-1R: A key linker between chemoresistance and cancer stem cells in epithelial ovarian cancer cells
Generation of chemoresistance and tumor relapse is major therapeutic barriers for successful treatment of ovarian cancer. According to the current notion, a small population of cells (Cancer Stem Cells ... that governs…
Research article · 12 Aug 2016 Prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
cancer stem cells (CSCs) and clinicopathological features and its effect on the survival of ovarian cancer patients. A comprehensive literature search in the electronic databases, including PubMed, EMBASE, and Wanfang…
Conference abstract Cancer testis antigens: Novel targets for ovarian cancer
Conference abstract Cancer testis antigens: Novel targets for ovarian cancer
Ovarian cancer is the fifth leading cause of cancer death in women and the leading cause from gynecological malignancies. Despite the recently improved outcomes of new chemotherapeutical agents ... therapy of ovarian…
Commentary · 28 Jan 2023 Targeting Cancer Stem Cells: A Potential Breakthrough in Ovarian Cancer Treatment

